Understanding the Disease Process
Pulmonary fibrosis is a severe disease that affects the human lungs. In particular, the disease appears due to specific lung damage (Meyer & Nathan, 2018). Noteworthy, the result is challenging and impaired breathing (Meyer & Nathan, 2018). According to Meyer and Nathan (2018), Pulmonary fibrosis is a “disease that progresses in a relentless and often insidious manner, with median survival estimates of 2-3 years from the time of diagnosis” (p. 11).
It is, therefore, essential to address the symptoms of the disease and take the necessary treatment measures as quickly as possible. However, it is necessary to note that patients have different outcomes in the context of disease progression. In some, significant complications associated with the respiratory process occur gradually, while in others, there is a sharp deterioration in the ability to breathe, which leads to death (Meyer & Nathan, 2018). It is important to consider each case individually and take appropriate treatment measures.
Alterations in Normal Body Function
As an alteration of the normal function of this body system, one should highlight the significant changes in the ability to breathe. Moreover, as side-effects of the disease, it is vital to note dry cough and fatigue, which can worsen the situation if the appropriate treatment is absent (Swigris & Brown, 2018).
Diagnostic Tests for Disease Identification
To determine the possibility of this disease based on particular symptoms, it is vital to use a chest X-ray to obtain the necessary information about the lung condition (Meyer & Nathan, 2018). By examining the lung scan, the doctor can conclude the presence of the disease and the extent of lung damage (Meyer & Nathan, 2018). In addition, some doctors use the method of pulmonary function tests, which can be effective in certain situations.
Genetic and Cultural Factors Influencing the Disease
Next, it is essential to highlight the factors that can be the causes of the disease. In the book Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide, Meyer and Nathan (2018) consider various causes of Pulmonary Fibrosis. Among the main ones are the effects of human activities such as smoking, some types of work as a miner, and others (Meyer & Nathan, 2018).
The main elements that cause lung damage when inhaled are metal dust, wood dust, sand, and others (Meyer & Nathan, 2018). In the context of the terrible and harsh working conditions in some professions, it is important to consider a quotation from the Bible. According to Ryrie (1973), “There is neither Jew nor Gentile, neither slave nor free, nor is there male and female, for you are all one in Christ Jesus” (Galatians 3:28). Therefore, it is critical to creating conditions that do not negatively affect human health, as diseases such as Pulmonary Fibrosis can also result in death. In some cultures, such measures are ignored, with severe consequences.
Treatment Approaches for the Disease
Pulmonary Fibrosis can be treated in different ways depending on the degree of lung damage. Among the most popular methods is to help the patient with breathing with various procedures and medications. In particular, oxygen therapy is used to saturate the lungs with sufficient oxygen (Swigris & Brown, 2018). However, the patient’s treatment often involves using additional medical equipment that allows them to breathe if the disease is in the advanced stage. As an impact, if not treated, various disease scenarios, including lethal ones, are possible. The lungs will continue to deteriorate, and the person will find breathing increasingly difficult.
Education and Support for Patients on Disease Management
It is important to stress that medical specialists, nurses, and doctors should permanently carry out specific educational programs. Nurses can use the telehealth approach to continuously monitor the patient’s condition and provide essential recommendations (Swigris & Brown, 2018). In general, a doctor should supervise treatment, as it is vital to periodically x-ray the lungs to monitor the progress or regress of treatment.
References
Meyer, K. C., & Nathan, S. D. (2018). Idiopathic pulmonary fibrosis: A comprehensive clinical guide. Springer International Publishing.
Ryrie, C. C. (1973). New International Version (NIV). Biblica. Web.
Swigris, J., & Brown, K. K. (2018). Idiopathic pulmonary fibrosis. Elsevier Health Sciences.
